Eledon Pharmaceuticals (ELDN) Competitors $3.32 +0.16 (+5.06%) As of 02:41 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ELDN vs. DAWN, OCS, CVAC, ABCL, RCKT, ZYME, QURE, XNCR, LENZ, and PAHCShould you be buying Eledon Pharmaceuticals stock or one of its competitors? The main competitors of Eledon Pharmaceuticals include Day One Biopharmaceuticals (DAWN), Oculis (OCS), CureVac (CVAC), AbCellera Biologics (ABCL), Rocket Pharmaceuticals (RCKT), Zymeworks (ZYME), uniQure (QURE), Xencor (XNCR), LENZ Therapeutics (LENZ), and Phibro Animal Health (PAHC). These companies are all part of the "pharmaceutical products" industry. Eledon Pharmaceuticals vs. Day One Biopharmaceuticals Oculis CureVac AbCellera Biologics Rocket Pharmaceuticals Zymeworks uniQure Xencor LENZ Therapeutics Phibro Animal Health Day One Biopharmaceuticals (NASDAQ:DAWN) and Eledon Pharmaceuticals (NASDAQ:ELDN) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, risk, community ranking, dividends, analyst recommendations, profitability, earnings and valuation. Which has preferable earnings and valuation, DAWN or ELDN? Eledon Pharmaceuticals has lower revenue, but higher earnings than Day One Biopharmaceuticals. Day One Biopharmaceuticals is trading at a lower price-to-earnings ratio than Eledon Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDay One Biopharmaceuticals$131.16M5.93-$188.92M-$1.08-7.11Eledon PharmaceuticalsN/AN/A-$116.54M-$2.36-1.41 Does the MarketBeat Community favor DAWN or ELDN? Day One Biopharmaceuticals received 26 more outperform votes than Eledon Pharmaceuticals when rated by MarketBeat users. However, 73.68% of users gave Eledon Pharmaceuticals an outperform vote while only 70.13% of users gave Day One Biopharmaceuticals an outperform vote. CompanyUnderperformOutperformDay One BiopharmaceuticalsOutperform Votes5470.13% Underperform Votes2329.87% Eledon PharmaceuticalsOutperform Votes2873.68% Underperform Votes1026.32% Which has more volatility and risk, DAWN or ELDN? Day One Biopharmaceuticals has a beta of -1.24, suggesting that its stock price is 224% less volatile than the S&P 500. Comparatively, Eledon Pharmaceuticals has a beta of 0.66, suggesting that its stock price is 34% less volatile than the S&P 500. Do analysts rate DAWN or ELDN? Day One Biopharmaceuticals presently has a consensus price target of $32.29, suggesting a potential upside of 320.55%. Eledon Pharmaceuticals has a consensus price target of $12.50, suggesting a potential upside of 276.51%. Given Day One Biopharmaceuticals' stronger consensus rating and higher probable upside, equities analysts plainly believe Day One Biopharmaceuticals is more favorable than Eledon Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Day One Biopharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 3.13Eledon Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals and insiders hold more shares of DAWN or ELDN? 87.9% of Day One Biopharmaceuticals shares are held by institutional investors. Comparatively, 56.8% of Eledon Pharmaceuticals shares are held by institutional investors. 6.2% of Day One Biopharmaceuticals shares are held by company insiders. Comparatively, 11.7% of Eledon Pharmaceuticals shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Is DAWN or ELDN more profitable? Day One Biopharmaceuticals' return on equity of -22.40% beat Eledon Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Day One BiopharmaceuticalsN/A -22.40% -19.79% Eledon Pharmaceuticals N/A -189.99%-28.17% Does the media refer more to DAWN or ELDN? In the previous week, Day One Biopharmaceuticals had 2 more articles in the media than Eledon Pharmaceuticals. MarketBeat recorded 9 mentions for Day One Biopharmaceuticals and 7 mentions for Eledon Pharmaceuticals. Eledon Pharmaceuticals' average media sentiment score of 1.17 beat Day One Biopharmaceuticals' score of 0.52 indicating that Eledon Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Day One Biopharmaceuticals 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Eledon Pharmaceuticals 5 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryDay One Biopharmaceuticals beats Eledon Pharmaceuticals on 11 of the 17 factors compared between the two stocks. Get Eledon Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ELDN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ELDN vs. The Competition Export to ExcelMetricEledon PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$198.81M$6.74B$5.50B$7.96BDividend YieldN/A3.05%5.11%4.23%P/E Ratio-1.657.3822.6318.55Price / SalesN/A241.88397.30103.38Price / CashN/A65.8538.1834.62Price / Book11.076.476.704.25Net Income-$116.54M$143.68M$3.23B$248.27M7 Day Performance-1.19%1.85%1.36%1.28%1 Month Performance3.11%6.73%3.85%3.75%1 Year Performance44.98%-2.72%15.87%5.31% Eledon Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ELDNEledon Pharmaceuticals2.18 of 5 stars$3.32+5.1%$12.50+276.5%+32.2%$198.81MN/A-1.6510Upcoming EarningsShort Interest ↑News CoveragePositive NewsDAWNDay One Biopharmaceuticals2.4766 of 5 stars$7.74flat$32.29+317.1%-54.5%$784.48M$131.16M-7.5160Upcoming EarningsNews CoverageOCSOculis2.8615 of 5 stars$17.86+5.1%$30.25+69.4%+33.1%$779.80M$980,000.00-9.252Short Interest ↓News CoverageCVACCureVac3.9574 of 5 stars$3.47+7.4%$16.00+361.1%+40.9%$778.45M$535.18M6.31880Analyst ForecastABCLAbCellera Biologics2.596 of 5 stars$2.59+0.8%$7.50+189.6%-31.0%$771.79M$28.83M-4.25500Upcoming EarningsGap DownRCKTRocket Pharmaceuticals4.6773 of 5 stars$7.16-1.0%$43.00+500.6%-64.5%$763.47MN/A-2.60240Upcoming EarningsZYMEZymeworks2.761 of 5 stars$12.88+2.5%$21.00+63.0%+51.6%$761.87M$76.30M-8.59460Upcoming EarningsAnalyst RevisionPositive NewsQUREuniQure2.5691 of 5 stars$13.97-1.5%$38.80+177.7%+234.7%$755.46M$27.12M-2.82500Upcoming EarningsShort Interest ↑Analyst RevisionXNCRXencor3.5285 of 5 stars$10.60+0.9%$33.86+219.4%-47.4%$754.21M$110.49M-3.31280Upcoming EarningsAnalyst ForecastNews CoveragePositive NewsLENZLENZ Therapeutics1.9507 of 5 stars$27.27+1.5%$46.60+70.9%+79.6%$751.10MN/A-5.72110Positive NewsPAHCPhibro Animal Health3.3414 of 5 stars$18.43+2.4%$19.75+7.2%+11.4%$746.47M$1.11B38.401,860Upcoming EarningsPositive News Related Companies and Tools Related Companies DAWN Competitors OCS Competitors CVAC Competitors ABCL Competitors RCKT Competitors ZYME Competitors QURE Competitors XNCR Competitors LENZ Competitors PAHC Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ELDN) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eledon Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eledon Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
